ArticleIJID regions2022
Favourable outcomes of non-O1, non-O139
Article in IJID regions, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 3 citations in OpenAlex.
- Article
- Bacteremia by non-O1/non-O139 Vibrio cholerae: Case description and literature review.Biomedica : revista del Instituto Nacional de Salud · 2023Review
- An Unusual Case of NeonatalJournal of global infectious diseasesArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Non-O1, non-O139 Aim: To describe the clinical spectrum, treatment practices and outcome of NOVC bacteraemia. Methods: Eight patients with NOVC bacteraemia admitted to two large tertiary care hospitals in Oman were identified over a 10-year period (2010-2020). Data were extracted retrospectively from the hospital patient data management. Results: Six (75.0%) patients were male, and the median age of patients was 67.5 years. The majority of cases (87.5%) were not associated with travel and no clear sources were identified. All patients had predisposing factors including diabetes mellitus, chronic liver disease or malignancies. Gastrointestinal symptoms were the predominant manifestations in 75.0% of cases, but diarrhoea was only reported in one patient. Conclusions: Early presentation (median interval from symptom onset to presentation 1.5 days), appropriate management and highly susceptible isolates may have contributed to the favourable outcome, as there were no cases of death or severe course of infection. All patients were discharged home after a median of 9 days of hospitalization.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.